Back to Steward Partners Investment Advisory, LLC Steward Partners Investment Advisory, LLC

BMEZBMEZ
24 quarters

Position history for Steward Partners Investment Advisory, LLCSteward Partners Investment Advisory, LLC's holdings in BLACKROCK HEALTH SCIENCES TE

Steward Partners Investment Advisory, LLC holds 14,166 shares of BMEZ (BLACKROCK HEALTH SCIENCES TE), worth $217,444 as of 2026-Q2. The position was decreased (-12.8% shares). BMEZ represents 0.0% of Steward Partners Investment Advisory, LLC's portfolio.

Current Value

$217,444

Current Shares

14,166

Total Value Change

-$118,556

Total Shares Change

+96

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
14,166
-12.8%
$217,4440.0%$15.24
0
2026-Q1
Increased
16,244
+10.6%
$233,2660.0%$13.93
26
2025-Q4
Increased
14,687
+4.9%
$221,0460.0%$14.28
24
2025-Q3
Decreased
13,999
-74.2%
$201,8680.0%$13.38
0
2025-Q2
Decreased
54,294
-6.8%
$774,2260.0%$12.78
0
2025-Q1
Increased
58,230
+24.7%
$867,6250.0%$12.89
30
2024-Q4
Decreased
46,706
-0.3%
$672,5670.0%$12.03
0
2024-Q3
Increased
46,831
+13.5%
$741,7970.0%$12.79
28
2024-Q2
Increased
41,276
+2.6%
$633,9970.0%$12.00
25
2024-Q1
Decreased
40,217
-9.7%
$659,1530.0%$12.50
0
2023-Q4
Decreased
44,522
-2.5%
$652,2430.0%$10.98
0
2023-Q3
Increased
45,684
+14.6%
$658,3070.0%$10.59
28
2023-Q2
Increased
39,851
+21.0%
$654,3570.0%$11.74
29
2023-Q1
Increased
32,926
+21.6%
$550,1940.0%$11.63
29
2022-Q4
Decreased
27,068
-8.7%
$417,6570.0%$10.45
0
2022-Q3
Increased
29,642
+35.6%
$443,0000.0%$9.84
31
2022-Q2
Increased
21,867
+37.4%
$359,0000.0%$10.54
31
2022-Q1
Increased
15,910
+58.5%
$319,0000.0%$12.54
34
2021-Q4
Increased
10,038
+79.8%
$255,0000.0%$15.52
35
2021-Q3
Increased
5,584
+22.0%
$151,0000.0%$16.20
27
2021-Q2
Decreased
4,578
-96.7%
$132,0000.0%$17.10
0
2021-Q1
New
137,738
-
$1.8B0.0%$15.30
44
2020-Q4
Exited
0
-100.0%
$00.0%$16.47
0
2020-Q3
New
14,070
-
$336,0000.0%$13.56
33

Other major holders of BMEZ: Saba Capital Management, L.P., UBS Group AG

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used